Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EQU-001 by Equilibre Biopharmaceuticals for Epilepsy: Likelihood of Approval
EQU-001 is under clinical development by Equilibre Biopharmaceuticals and currently in Phase II for Epilepsy. According to GlobalData, Phase II...